Literature DB >> 30850274

Distinct functions of Trio GEF domains in axon outgrowth of cerebellar granule neurons.

Tao Tao1, Jie Sun1, Yajing Peng1, Pei Wang1, Xin Chen1, Wei Zhao1, Yeqiong Li1, Lisha Wei1, Wei Wang1, Yanyan Zheng1, Ye Wang1, Xuena Zhang1, Min-Sheng Zhu2.   

Abstract

As a critical guanine nucleotide exchange factor (GEF) regulating neurite outgrowth, Trio coordinates multiple processes of cytoskeletal dynamics through activating Rac1, Cdc42 and RhoA small GTPases by two GEF domains, but the in vivo roles of these GEF domains and corresponding downstream effectors have not been determined yet. We established multiple lines of knockout mice and assessed the respective roles of Trio GEF domains and Rac1 in axon outgrowth. Knockout of total Trio in cerebellar granule neurons (CGNs) led to an impaired F-actin rearrangement of growth cone and hence a retarded neurite outgrowth. Such a retardation was reproduced by inhibition of GEF1 domain or knockdown of Cdc42 and restored apparently by introduction of active Cdc42. As Rac1 deficiency did not affect the neurite outgrowth of CGNs, we suggested that Trio GEF1-mediated Cdc42 activation was required for neurite outgrowth. We established a GEF2-knockout line with deletion of all Trio isoforms except a cerebella-specific Trio8, a short isoform of Trio without GEF2 domain, and used this line as a GEF2-deficient animal model. The GEF2-deficient CGNs had a normal neurite outgrowth but abolished Netrin-1-promoted growth, without affecting Netrin-1 induced Rac1 activation. We thus suggested that Trio GEF1-mediated Cdc42 activation rather than Rac1 activation drives the F-actin dynamics necessary for neurite outgrowth, while GEF2 functions in Netrin-1-promoted neurite elongation. Our results delineated the distinct roles of Trio GEF domains in neurite outgrowth, which is instructive to understand the pathogenesis of clinical Trio-related neurodevelopmental disorders.
Copyright © 2019 Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, and Genetics Society of China. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Axon outgrowth; Cerebellar granule neuron; GEF; Rho GTPases; Trio

Mesh:

Substances:

Year:  2019        PMID: 30850274     DOI: 10.1016/j.jgg.2019.02.003

Source DB:  PubMed          Journal:  J Genet Genomics        ISSN: 1673-8527            Impact factor:   4.275


  5 in total

1.  Novel rearrangements between different chromosomes with direct impact on the diagnosis of 5p- syndrome.

Authors:  Samar Nasser Chehimi; Vanessa Tavares Almeida; Amom Mendes Nascimento; Évelin Aline Zanardo; Yanca Gasparini de Oliveira; Gleyson Francisco da Silva Carvalho; Beatriz Martins Wolff; Marilia Moreira Montenegro; Nilson Antônio de Assunção; Chong Ae Kim; Leslie Domenici Kulikowski
Journal:  Clinics (Sao Paulo)       Date:  2022-05-28       Impact factor: 2.898

2.  Opposite Modulation of RAC1 by Mutations in TRIO Is Associated with Distinct, Domain-Specific Neurodevelopmental Disorders.

Authors:  Sónia Barbosa; Stephanie Greville-Heygate; Maxime Bonnet; Annie Godwin; Christine Fagotto-Kaufmann; Andrey V Kajava; Damien Laouteouet; Rebecca Mawby; Htoo Aung Wai; Alexander J M Dingemans; Jayne Hehir-Kwa; Marjorlaine Willems; Yline Capri; Sarju G Mehta; Helen Cox; David Goudie; Fleur Vansenne; Peter Turnpenny; Marie Vincent; Benjamin Cogné; Gaëtan Lesca; Jozef Hertecant; Diana Rodriguez; Boris Keren; Lydie Burglen; Marion Gérard; Audrey Putoux; Vincent Cantagrel; Karine Siquier-Pernet; Marlene Rio; Siddharth Banka; Ajoy Sarkar; Marcie Steeves; Michael Parker; Emma Clement; Sébastien Moutton; Frédéric Tran Mau-Them; Amélie Piton; Bert B A de Vries; Matthew Guille; Anne Debant; Susanne Schmidt; Diana Baralle
Journal:  Am J Hum Genet       Date:  2020-02-27       Impact factor: 11.025

3.  Novel loss-of-function variants in TRIO are associated with neurodevelopmental disorder: case report.

Authors:  Laura Schultz-Rogers; Karthik Muthusamy; Filippo Pinto E Vairo; Eric W Klee; Brendan Lanpher
Journal:  BMC Med Genet       Date:  2020-11-10       Impact factor: 2.103

4.  Trio cooperates with Myh9 to regulate neural crest-derived craniofacial development.

Authors:  Shuyu Guo; Li Meng; Haojie Liu; Lichan Yuan; Na Zhao; Jieli Ni; Yang Zhang; Jingjing Ben; Yi-Ping Li; Junqing Ma
Journal:  Theranostics       Date:  2021-02-25       Impact factor: 11.556

5.  Rho-GEF Trio regulates osteosarcoma progression and osteogenic differentiation through Rac1 and RhoA.

Authors:  Junyi Wang; Lichan Yuan; Xiaohong Xu; Zhongyin Zhang; Yuhuan Ma; Leilei Hong; Junqing Ma
Journal:  Cell Death Dis       Date:  2021-12-11       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.